CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 30 target
Drug / intervention
NeuroVisiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00348218
NCT00348218Phase 1Completed
CompareCT.gov

Pilot Study To Evaluate The Efficacy Of Neurovision'S NVC™- Vision Correction Technology For The Improvement In Visual Acuity In Myopic Children And Slowing Down Of Myopia Progression

Singapore National Eye Centre·interventional·Posted Jul 4, 2006·Updated May 12, 2010

In Brief

A Phase 1 clinical trial evaluating NeuroVision for Myopia. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This is a pilot study to assess the effectiveness of Neurovision treatment in the improvement of vision in children being under-corrected and to assess the effectiveness of Neurovision treatment in slowing down myopia progression in children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesSingapore
CollaboratorsNeuroVision, Health Promotion Board, Singapore

Timeline

Phase 1CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 4, 2006
Enrollment StartJun 1, 2006
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 20.0 years ago

Interventions

NeuroVisiondevice